Inflammation and Change in Body Weight with Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults

Journal of Infectious Diseases

Volumn 214, Issue 1, 2016, Pages 65-72

  Mave, Vidya ^a,b   Erlandson, Kristine M ^c   Gupte, Nikhil ^a,b   Balagopal, Ashwin ^b   Asmuth, David M ^d   Campbell, Thomas B ^c   Smeaton, Laura ^e   Kumarasamy, Nagalingeswaran ^f   Hakim, James ^g   Santos, Breno ^h   Riviere, Cynthia ⁱ   Hosseinipour, Mina C ^j   Sugandhavesa, Patcharaphan ^k   Infante, Rosa ^l   Pillay, Sandy ^m   Cardoso, Sandra W ⁿ   Tripathy, Srikanth ^o   Mwelase, Noluthando ^p   Berendes, Sima ^q,r   Andrade, Bruno B ^s,t   Thomas, David L ^b   Bollinger, Robert C ^b   Gupta, Amita ^a,b   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^g UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^h Neonatal Unit   (Brazil)

ⁱ Centers Institute of Infectious Diseases and Reproductive Health   (Haïti)

^j UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^k Research Institute for Health Sciences   (Thailand)

^l ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^m DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

ⁿ Funda??o Oswaldo Cruz   (Brazil)

^o NATIONAL AIDS RESEARCH INSTITUTE   (India)

^p UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^q UNIVERSITY OF MALAWI   (Malawi)

^r LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^s INSTITUTO OSWALDO CRUZ   (Brazil)

^t Instituto Brasileiro para A Investigação da Tuberculose   (Brazil)

more..

Author keywords

body mass index; HAART clinical outcomes; HIV AIDS; immune activation inflammation; noncommunicable diseases

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; CD14 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18; INTERLEUKIN 6; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS LOAD; WEIGHT CHANGE; WEIGHT GAIN; BRAZIL; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; HAITI; HIV INFECTIONS; INDIA; MALAWI; MALE; PERU; RANDOMIZED CONTROLLED TRIAL; SOUTH AFRICA; THAILAND; UNITED STATES; WEIGHT REDUCTION; ZIMBABWE;

ADULT; ANTI-HIV AGENTS; BODY WEIGHT; BRAZIL; COHORT STUDIES; FEMALE; HAITI; HIV INFECTIONS; HUMANS; INDIA; INFLAMMATION; MALAWI; MALE; PERU; PROSPECTIVE STUDIES; SOUTH AFRICA; THAILAND; UNITED STATES; WEIGHT GAIN; WEIGHT LOSS; ZIMBABWE;

EID: 84979208004     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw096     Document Type: Article

References (48)

1. World Health Organization: 2015 Global Health Observatory data. http://www. who.int/gho/hiv/en/. Accessed 8 March 2015
2. Crum-Cianflone N, Roediger MP, Eberly L, et al. Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One 2010; 5:e10106
3. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS 2000; 22:925-30
4. Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis 2004; 39:1223-30
5. Erlandson KM, Kitch D, Tierney C, et al.Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density. AIDS 2013; 27:2069-79
6. Yuh B, Tate J, Butt AA, et al. Weight change after antiretroviral therapy and mortality. Clin Infect Dis 2015; 60:1852-9
7. Mallon PW, Miller J, Cooper DA, Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS 2003; 17:971-9
8. Hurley E, Coutsoudis A, Giddy J, Knight SE, Loots E, Esterhuizen TM. Weight evolution and perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African urban setting. S Afr Med J 2011; 101:645-50
9. Maia Leite LH, De Mattos Marinho Sampaio AB. Progression to overweight, obesity and associated factors after antiretroviral therapy initiation among Brazilian persons with HIV/AIDS. Nutr Hosp 2010; 25:635-40
10. Boodram B, Plankey MW, Cox C, et al. Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in theWomen's Interagency HIV Study. AIDS Patient Care STDS 2009; 23:1009-16
11. Buchacz K, Baker RK, Palella FJ Jr., et al. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther 2013; 18:65-75
12. Wand H, Ramjee G. High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa: healthy diet and life style messages should be integrated into HIV prevention programs. BMC Public Health 2013; 13:159
13. Fontbonne A, Cournil A, Cames C, et al. Anthropometric characteristics and cardiometabolic risk factors in a sample of urban-dwelling adults in Senegal. Diabetes Metab 2011; 37:52-8
14. Sudfeld CR, Isanaka S, Mugusi FM, et al. Weight change at 1 mo of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4T cell reconstitution in a Tanzanian HIV-infected adult cohort. Am J Clin Nutr 2013; 97:1278-87
15. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6:772-83
16. Lihn AS, Richelsen B, Pedersen SB, et al. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab 2003; 285:E1072-80
17. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92:1023-33
18. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-808
19. Seelaender MC, Batista ML. Adipose tissue inflammation and cancer cachexia: the role of steroid hormones. Horm Mol Biol Clin Investig 2014; 17:5-12
20. De Pablo-Bernal RS, Ruiz-Mateos E, Rosado I, et al. TNF-alpha levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIVuninfected subjects. J Antimicrob Chemother 2014; 69:3041-6
21. Wada NI, Jacobson LP, Margolick JB, et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS 2015; 29:463-71
22. Tenorio AR, Zheng Y, Bosch RJ, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis 2014; 210:1248-59
23. Tien PC, Choi AI, Zolopa AR, et al. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 2010; 55:316-22
24. Brown TT, Tassiopoulos K, Bosch RJ, Shikuma C, McComsey GA. Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care 2010; 33:2244-9
25. Crawford KW, Li X, Xu X, et al. Lipodystrophy and inflammation predict later grip strength in HIV-infected men: the MACS Body Composition substudy. AIDS Res Hum Retroviruses 2013; 29:1138-45
26. Erlandson KM, Allshouse AA, Jankowski CM, et al. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 2013; 208:249-59
27. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation markers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203
28. Erlandson KM, Campbell TB. Inflammation in chronic HIV infection: what can we do? J Infect Dis 2015; 212:339-42
29. Campbell TB, Smeaton LM, Kumarasamy N, et al. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med 2012; 9:e1001290
30. Tenforde MW, Gupte N, Dowdy DW, et al. C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS One 2015; 10:e0117424
31. NHLBI Obesity Education Initiative. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. NIH publication no. 98-4083. Bethesda, MD: Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, 1998
32. Erlandson KM, Taejaroenkul S, Smeaton L, Gupta A, Singini IL, et al. A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings. Open Forum Infect Dis 2015; 2:ofv095
33. Achhra AC, Mocroft A, Reiss P, et al. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Med 2015. In press
34. Imamura F, Micha R, Khatibzadeh S, et al. Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob Health 2015; 3:e132-42
35. Koethe JR, Blevins M, Nyirenda C, et al. Nutrition and inflammation serum markers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia. J Int AIDS Soc 2011; 14:19
36. Longenecker CT, Jiang Y, Orringer CE, et al. Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection. AIDS 2014; 28:969-77
37. Funderburg NT, Zidar DA, Shive C, et al. Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. Blood 2012; 120:4599-608
38. Sandler NG,Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203:780-90
39. Silva EF, Charreau I, Gourmel B, et al. Decreases in inflammatory and coagulation markers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy. J Infect Dis 2013; 208:892-7
40. Lake JE, McComsey GA, Hulgan T, et al. Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial. HIV Med 2014; 15:431-41
41. Manco M, Fernandez-Real JM, Equitani F, et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 2007; 92:483-90
42. Redd AD, Eaton KP, Kong X, et al. C-reactive protein levels increase during HIV-1 disease progression in Rakai, Uganda, despite the absence of microbial translocation. J Acquir Immune Defic Syndr 2010; 54:556-9
43. Boulware DR, Hullsiek KH, Puronen CE, et al. Higher levels of CRP, D-dimer, IL- 6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 2011; 203:1637-46
44. Vilarrasa N, Vendrell J, Sanchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factoralpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol 2007; 67:679-86
45. Vilarrasa N, Vendrell J, Maravall J, et al. IL-18: relationship with anthropometry, body composition parameters, leptin and arterial hypertension. Horm Metab Res 2006; 38:507-12
46. Tan HY, Yong YK, Andrade BB, et al. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2015; 29:421-31
47. Conley LJ, Bush TJ, Rupert AW, et al. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy. AIDS 2015; 29:2201-7
48. Shivakoti R, Yang WT, Berendes S, Mwelase N, et al. Persistently elevated C-reactive protein level in the first year of antiretroviral therapy, despite virologic suppression, is associated with HIV disease progression in resourceconstrained settings. J Infect Dis 2016; 213:1074-8